Rapid-onset depression therapy reshapes the field
Esketamine, oral postpartum depression therapy, and pipeline rapid-acting agents are changing the timing assumption built into depression care.
Depression care has historically been built around the assumption that therapy takes weeks to work. Rapid-onset agents - esketamine, oral postpartum-depression therapy, and several pipeline programs - challenge that assumption. The clinical and access infrastructure was designed for the old timing; it is being renegotiated.
Continue reading
Full intelligence on PanaceaIntel
PatientSpotlight publishes the headline framing. The full brief, the editorial takeaway, and the source list sit on PanaceaIntel for entitled clients.
New to PanaceaIntel? Request access and the team will reply within one working day.
Related
← Back to Signals
Published by PatientSpotlight, by PanaceaIntel.